BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: den Bakker E, Gemke RJBJ, Bökenkamp A. Endogenous markers for kidney function in children: a review. Critical Reviews in Clinical Laboratory Sciences 2018;55:163-83. [DOI: 10.1080/10408363.2018.1427041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Thompson LE, Joy MS. Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption. Current Opinion in Toxicology 2022;31:100344. [DOI: 10.1016/j.cotox.2022.03.005] [Reference Citation Analysis]
2 Zhao S, Liu Y, Zhou C, Chen Z, Cai Z, Han J, Xiao J, Xiao Q. Prediction model of delayed graft function based on clinical characteristics combined with serum IL-2 levels. BMC Nephrol 2022;23:284. [PMID: 35971094 DOI: 10.1186/s12882-022-02908-2] [Reference Citation Analysis]
3 Sivanathan PC, Ooi KS, Mohammad Haniff MAS, Ahmadipour M, Dee CF, Mokhtar NM, Hamzah AA, Chang EY. Lifting the Veil: Characteristics, Clinical Significance, and Application of β-2-Microglobulin as Biomarkers and Its Detection with Biosensors. ACS Biomater Sci Eng 2022. [PMID: 35848712 DOI: 10.1021/acsbiomaterials.2c00036] [Reference Citation Analysis]
4 Veltkamp F, Bökenkamp A, Slaats J, Hamer H, Bouts AHM. Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C. Pediatr Nephrol 2022. [PMID: 35416496 DOI: 10.1007/s00467-022-05547-9] [Reference Citation Analysis]
5 Daetwyler E, Bargetzi M, Otth M, Scheinemann K. Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review. BMC Cancer 2022;22:267. [PMID: 35287628 DOI: 10.1186/s12885-021-09145-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hornum M, Houlind MB, Iversen E, Porrini E, Luis-Lima S, Oturai P, Iversen M, Bredahl P, Carlsen J, Møller CH, Andersen MJ, Feldt-Rasmussen B, Perch M. Estimating Renal Function Following Lung Transplantation. J Clin Med 2022;11:1496. [PMID: 35329822 DOI: 10.3390/jcm11061496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mikulic V, Rogic D, Mikulic I, Jerkovic Raguz M, Brzica J, Pandza Topic M, Ljubić K, Tomic V. Cystatin C Concentration During the First Three Postnatal Days in Healthy Term Newborns. Z Geburtshilfe Neonatol 2022. [PMID: 35081646 DOI: 10.1055/a-1727-6309] [Reference Citation Analysis]
8 Sager C, Burek C, Gomez YR, Weller S, Ruiz J, Imizcoz FL, Szklarz T, Rosiere N, Monteverde M, Campmany L, Vazquez JA, De Castro F, Bernardez L, Adragna M, Corbetta JP. Nephro-urological outcomes of a proactive management of children with spina bifida in their first 5 Years of life. J Pediatr Urol 2021:S1477-5131(21)00584-2. [PMID: 34991991 DOI: 10.1016/j.jpurol.2021.12.002] [Reference Citation Analysis]
9 van de Velde ME, den Bakker E, Blufpand HN, Kaspers GL, Abbink FCH, Kors AWA, Wilhelm AJ, Honeywell RJ, Peters GJ, Stoffel-Wagner B, Buffart LM, Bökenkamp A. Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters. Cancers (Basel) 2021;13:5963. [PMID: 34885072 DOI: 10.3390/cancers13235963] [Reference Citation Analysis]
10 Grubb A. Glomerular filtration and shrunken pore syndrome in children and adults. Acta Paediatr 2021;110:2503-8. [PMID: 33742469 DOI: 10.1111/apa.15846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Woillard JB, Bouchet S, Fayon M, Marquet P, Monchaud C, Bui S. A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic Fibrosis. Ther Drug Monit 2021;43:499-504. [PMID: 33346630 DOI: 10.1097/FTD.0000000000000855] [Reference Citation Analysis]
12 Baliga MM, Klawitter J, Christians U, Hopp K, Chonchol M, Gitomer BY, Cadnapaphornchai MA, Klawitter J. Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease. Sci Rep 2021;11:6629. [PMID: 33758231 DOI: 10.1038/s41598-021-84609-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Ebert N, Bevc S, Bökenkamp A, Gaillard F, Hornum M, Jager KJ, Mariat C, Eriksen BO, Palsson R, Rule AD, van Londen M, White C, Schaeffner E. Assessment of kidney function: clinical indications for measured GFR. Clin Kidney J 2021;14:1861-70. [PMID: 34345408 DOI: 10.1093/ckj/sfab042] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Oh Y, Park S, Park E, Lee J, Lee H, Kim J, Cho J. Correlation between vancomycin clearance and cystatin C-based glomerular filtration rate in paediatric patients. Br J Clin Pharmacol 2021;87:3190-6. [PMID: 33496976 DOI: 10.1111/bcp.14733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Orabueze IC, Babalola R, Azuonwu O, Okoko II, Asare G. Evaluation of possible effects of Persea americana seeds on female reproductive hormonal and toxicity profile. J Ethnopharmacol 2021;273:113870. [PMID: 33484907 DOI: 10.1016/j.jep.2021.113870] [Reference Citation Analysis]
16 Franck B, Woillard JB, Théorêt Y, Bittencourt H, Demers E, Briand A, Marquet P, Lapeyraque AL, Ovetchkine P, Autmizguine J. Population pharmacokinetics of ganciclovir and valganciclovir in paediatric solid organ and stem cell transplant recipients. Br J Clin Pharmacol 2021;87:3105-14. [PMID: 33373493 DOI: 10.1111/bcp.14719] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 den Bakker E, Musters M, Hubeek I, van Wijk JAE, Gemke RJBJ, Bokenkamp A. Concordance between creatinine- and cystatin C-based eGFR in clinical practice. Scand J Clin Lab Invest 2021;81:142-6. [PMID: 33459074 DOI: 10.1080/00365513.2021.1871776] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Oomen L, de Wall LL, Cornelissen EAM, Feitz WFJ, Bootsma-Robroeks CMHHT. Prognostic Factors on Graft Function in Pediatric Kidney Recipients. Transplant Proc 2021;53:889-96. [PMID: 33257001 DOI: 10.1016/j.transproceed.2020.10.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Fabre JB, Grelot L, Vanbiervielt W, Mazerie J, Manca R, Martin V. Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport. BMJ Open Sport Exerc Med 2020;6:e000849. [PMID: 33194223 DOI: 10.1136/bmjsem-2020-000849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 van Donge T, Staub E, Atkinson A, Gotta V, van den Anker J, Risch L, Welzel T, Pfister M. Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents. Clin Chem Lab Med 2020;59:373-82. [PMID: 32759403 DOI: 10.1515/cclm-2020-0781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Regev LC, Bouts AHM, Groothoff JW, van Wijk JAE, van Wijk M, van der Valk P, Bökenkamp A. A riddle wrapped in an enigma: acute kidney injury in a girl with Crohn's disease: Answers. Pediatr Nephrol 2020;35:1867-70. [PMID: 32232639 DOI: 10.1007/s00467-020-04538-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 den Bakker E, Gemke RJ, van Wijk JA, Hubeek I, Stoffel-wagner B, Bökenkamp A. Evidence for shrunken pore syndrome in children. Scandinavian Journal of Clinical and Laboratory Investigation 2020;80:32-8. [DOI: 10.1080/00365513.2019.1692231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Arora S, Dunkley L, Waldman LM, Chin VL, Umpaichitra V. Kidney function in minority children and adolescents with metabolically healthy and unhealthy obesity. Clin Obes 2020;10:e12345. [PMID: 31692279 DOI: 10.1111/cob.12345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Pavlaki A, Printza N, Farmaki E, Stabouli S, Taparkou A, Sterpi M, Dotis J, Papachristou F. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants. Pediatr Nephrol 2020;35:163-70. [PMID: 31606750 DOI: 10.1007/s00467-019-04349-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
25 Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG. CKD: A Call for an Age-Adapted Definition. J Am Soc Nephrol 2019;30:1785-805. [PMID: 31506289 DOI: 10.1681/ASN.2019030238] [Cited by in Crossref: 58] [Cited by in F6Publishing: 84] [Article Influence: 19.3] [Reference Citation Analysis]
26 Katsoufis CP. Clinical predictors of chronic kidney disease in congenital lower urinary tract obstruction. Pediatr Nephrol 2020;35:1193-201. [PMID: 31197474 DOI: 10.1007/s00467-019-04280-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Björk J, Nyman U, Berg U, Delanaye P, Dubourg L, Goffin K, Grubb A, Hansson M, Littmann K, Åsling-Monemi K, Bökenkamp A, Pottel H. Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children. Pediatr Nephrol 2019;34:1087-98. [PMID: 30715595 DOI: 10.1007/s00467-018-4185-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
28 Dhont E, Van Der Heggen T, De Jaeger A, Vande Walle J, De Paepe P, De Cock PA. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients? Pediatr Nephrol 2020;35:25-39. [DOI: 10.1007/s00467-018-4120-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
29 den Bakker E, Gemke R, van Wijk JAE, Hubeek I, Stoffel-Wagner B, Bökenkamp A. Combining GFR estimates from cystatin C and creatinine-what is the optimal mix? Pediatr Nephrol 2018;33:1553-63. [PMID: 29774462 DOI: 10.1007/s00467-018-3973-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]